hBD-1 vs Elamipretide
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and Elamipretide (Elamipretide (MTP-131, SS-31)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | hBD-1 | Elamipretide |
|---|---|---|
| Category | Dental & Oral | Muscle & Performance |
| Full Name | Human beta-defensin 1 | Elamipretide (MTP-131, SS-31) |
| Molecular Weight | 4490 Da | 639.8 Da |
| Half-Life | minutes to hours | 1-4 hours |
| Amino Acids | 36 | 4 |
| Typical Dose | 1-10 µg/mL in experimental studies | 0.01-0.25 mg/kg/day |
| Route | Topical/Intraoral | Subcutaneous/Intravenous |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 120 |
| Research Status | Pre-clinical | Clinical |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
Elamipretide Benefits
- ✓mitochondrial protection
- ✓reduced oxidative stress
- ✓improved fatigue resistance
- ✓may support exercise tolerance
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
Elamipretide Dosing
0.01-0.25 mg/kg/day SC (clinical research)|daily dosing in trials|alternative IV protocols in some studies
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Elamipretide Side Effects
- ⚠nausea
- ⚠injection-site reactions
- ⚠diarrhea
- ⚠headache
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Elamipretide
Clinical and translational studies show elamipretide can improve mitochondrial function and some functional endpoints in mitochondrial disorders. Skeletal muscle research suggests benefits are driven by energy metabolism rather than direct muscle-building effects.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.